| 1 |
32169452 | Fucoidan increased the sensitivity to gefitinib in lung cancer cells correlates with reduction of TGFβ-mediated Slug expression. | 2020 Jun 15 |
3 |
| 2 |
31670920 | EGFR is a Therapeutic Target in Hormone Receptor-Positive Breast Cancer. | 2019 |
1 |
| 3 |
29467862 | Lentivirus-mediated silencing of HOTAIR lncRNA restores gefitinib sensitivity by activating Bax/Caspase-3 and suppressing TGF-α/EGFR signaling in lung adenocarcinoma. | 2018 Mar |
1 |
| 4 |
24486412 | Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells. | 2014 May |
1 |
| 5 |
23608755 | Transforming growth factor-α activates pancreatic stellate cells and may be involved in matrix metalloproteinase-1 upregulation. | 2013 Jun |
1 |
| 6 |
22863020 | Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors. | 2012 Nov |
3 |
| 7 |
21382168 | Transforming growth factor-α attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1. | 2011 Apr |
1 |
| 8 |
18811692 | Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer. | 2008 Nov |
1 |
| 9 |
16568376 | Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells. | 2006 Feb |
7 |
| 10 |
16585207 | Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines. | 2006 Apr 1 |
4 |
| 11 |
16685431 | Canonical WNT signaling pathway and human AREG. | 2006 Jun |
1 |
| 12 |
16230376 | Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers. | 2005 Oct 15 |
5 |
| 13 |
15387370 | Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839). | 2004 |
1 |